Delivery Order SPE2DB22D3011-SPE2DB24FQ4CP
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, a delivery order worth $1,080.06, is for the supply of 120 count capsules of the medication Mesalamine Extended Release 0.375 gram. The contract has a completion date of September 10, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, through its Corporate Office Division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,276.08, is for the delivery of 180 capsules of Mesalamine delayed-release 400 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $35,074.28 firm fixed-price delivery order is for the supply of 120 capsules of the prescription medication Mesalamine Extended-Release 0.375 gram. The contract has no set-aside designation and has an ultimate completion date of September 3, 2024. Amerisourcebergen, as a major pharmaceutical distributor, leverages its...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of 4,564,221,976 units of Mesalamine DR 400 mg capsules in 180-count bottles. The contract has a ceiling value of $24,666.61 and a period of performance through April 10, 2024....
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of 180 count bottles of 400 mg Mesalamine delayed-release capsules. The contract, valued at $2,348.72, was awarded by the Department of Defense's Medical Supply Chain agency on August 2, 2022, with an ultimate completion date of August 3, 2022. AmerisourceBergen, one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,879.92 contract is for the supply of 180 count capsules of the drug Mesalamine DR 400 mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.89 firm fixed-price delivery order is for the supply of 4,568,249,081 units of the prescription medication Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of 180 capsules of Mesalamine DR 400 mg, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $4,386.03 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Mesalamine 800 mg delayed-release tablet prescription medication. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $7,927.03 and a completion date of April 22, 2024. This contract is not set aside and is a Firm Fixed Price Delivery Order. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $12,703.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of 4,565,805,308 units of Mesalamine 800 mg delayed-release tablets in 180-count bottles. This is a delivery order contract with a firm-fixed price, and the ultimate completion date is September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...